TrkA overexpression enhances growth and metastasis of breast cancer cells

[1]  Kedar S Vaidya,et al.  BRMS1 suppresses breast cancer metastasis in multiple experimental models of metastasis by reducing solitary cell survival and inhibiting growth initiation , 2008, Clinical & Experimental Metastasis.

[2]  Kedar S Vaidya,et al.  BRMS1 suppresses breast cancer experimental metastasis to multiple organs by inhibiting several steps of the metastatic process. , 2008, The American journal of pathology.

[3]  H. Hondermarck,et al.  Nerve growth factor is a potential therapeutic target in breast cancer. , 2008, Cancer research.

[4]  D. Peeper,et al.  Critical role for TrkB kinase function in anoikis suppression, tumorigenesis, and metastasis. , 2007, Cancer research.

[5]  Robert D. Cardiff,et al.  Insights from transgenic mouse models of ERBB2-induced breast cancer , 2007, Nature Reviews Cancer.

[6]  L. Reichardt,et al.  Neurotrophin-regulated signalling pathways , 2006, Philosophical Transactions of the Royal Society B: Biological Sciences.

[7]  C. Cordon-Cardo,et al.  Autocrine PDGFR signaling promotes mammary cancer metastasis. , 2006, The Journal of clinical investigation.

[8]  N. Kyprianou,et al.  Anoikis and survival connections in the tumor microenvironment: is there a role in prostate cancer metastasis? , 2005, Cancer research.

[9]  R. Bachelder,et al.  Non-Angiogenic Functions of VEGF in Breast Cancer , 2005, Journal of Mammary Gland Biology and Neoplasia.

[10]  R. Kramer,et al.  Adhesion-mediated squamous cell carcinoma survival through ligand-independent activation of epidermal growth factor receptor. , 2004, The American journal of pathology.

[11]  I. Screpanti,et al.  TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma. , 2004, Cancer cell.

[12]  D. Peeper,et al.  Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB , 2004, Nature.

[13]  F. Akiyama,et al.  Efficacy and Safety of Trastuzumab as a Single Agent in Heavily Pretreated Patients with Her-2/NEU-Overexpressing Metastatic Breast Cancer , 2004, Tumori.

[14]  H. Hondermarck,et al.  Nerve growth factor overexpression and autocrine loop in breast cancer cells , 2003, Oncogene.

[15]  J. Nesland,et al.  Expression and activation of the nerve growth factor receptor TrkA in serous ovarian carcinoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[16]  D. Ribatti,et al.  Nerve growth factor–endothelial cell interaction leads to angiogenesis in vitro and in vivo , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  S. Hirohashi,et al.  Critical involvement of the phosphatidylinositol 3-kinase/Akt pathway in anchorage-independent growth and hematogeneous intrahepatic metastasis of liver cancer. , 2002, Cancer research.

[18]  Lyndsay N Harris,et al.  Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  F. Amenta,et al.  Neurotrophins and neurotrophin receptors in human lung cancer. , 2001, American journal of respiratory cell and molecular biology.

[20]  F. Révillion,et al.  Expression of nerve growth factor receptors and their prognostic value in human breast cancer. , 2001, Cancer research.

[21]  J. Peyrat,et al.  Nerve Growth Factor Stimulates Proliferation and Survival of Human Breast Cancer Cells through Two Distinct Signaling Pathways* , 2001, The Journal of Biological Chemistry.

[22]  P. Lazarovici,et al.  Tamoxifen inhibits nerve growth factor-induced proliferation of the human breast cancerous cell line MCF-7. , 2001, Cancer research.

[23]  M. Mesiti,et al.  Nerve Growth Factor Receptor Immunoreactivity in Breast Cancer Patients , 2001, Cancer investigation.

[24]  A. Weeraratna,et al.  Rational basis for Trk inhibition therapy for prostate cancer , 2000, The Prostate.

[25]  G. Barrett.  The p75 neurotrophin receptor and neuronal apoptosis , 2000, Progress in Neurobiology.

[26]  S. Ménard,et al.  Nerve Growth Factor Cooperates with p185 HER2 in Activating Growth of Human Breast Carcinoma Cells* , 2000, The Journal of Biological Chemistry.

[27]  H. Friess,et al.  Nerve growth factor expression correlates with perineural invasion and pain in human pancreatic cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  S. Baylin,et al.  Roles of trk family neurotrophin receptors in medullary thyroid carcinoma development and progression. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Bull,et al.  Expression of nerve growth factor receptors in cutaneous inflammation , 1998, The British journal of dermatology.

[30]  M. Chao.  The p75 neurotrophin receptor. , 1994, Journal of neurobiology.

[31]  A. Selman,et al.  Nerve growth factor and its high-affinity receptor trkA participate in the control of vascular endothelial growth factor expression in epithelial ovarian cancer. , 2007, Gynecologic oncology.

[32]  J. Nesland,et al.  Altered Expression and Activation of the Nerve Growth Factor Receptors TrkA and p75 Provide the First Evidence of Tumor Progression to Effusion in Breast Carcinoma , 2004, Breast Cancer Research and Treatment.

[33]  中西 一彰.  Critical involvement of the phosphatidylinositol 3-kinase/Akt pathway in anchorage-independent growth and hematogeneous intrahepatic metastasis of liver cancer , 2003 .

[34]  J. Mukai,et al.  Nerve growth factor-dependent regulation of NADE-induced apoptosis. , 2003, Vitamins and hormones.

[35]  S. Frisch,et al.  Anoikis mechanisms. , 2001, Current opinion in cell biology.

[36]  P. Lazarovici,et al.  Advances in Brief Tamoxifen Inhibits Nerve Growth Factor-induced Proliferation of the Human Breast Cancerous Cell Line MCF-71 , 2001 .